BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 10385247)

  • 1. Differential pharmacology between the guinea-pig and the gorilla 5-HT1D receptor as probed with isochromans (5-HT1D-selective ligands).
    Pregenzer JF; Alberts GL; Im WB; Slightom JL; Ennis MD; Hoffman RL; Ghazal NB; TenBrink RE
    Br J Pharmacol; 1999 May; 127(2):468-72. PubMed ID: 10385247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular cloning and pharmacological characterization of guinea pig 5-HT1B and 5-HT1D receptors.
    Zgombick JM; Bard JA; Kucharewicz SA; Urquhart DA; Weinshank RL; Branchek TA
    Neuropharmacology; 1997; 36(4-5):513-24. PubMed ID: 9225276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of ligand binding properties of the 5-HT1D receptors cloned from chimpanzee, gorilla and rhesus monkey in comparison with those from the human and guinea pig receptors.
    Pregenzer JF; Alberts GL; Bock JH; Slightom JL; Im WB
    Neurosci Lett; 1997 Oct; 235(3):117-20. PubMed ID: 9406883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Agonistic properties of alniditan, sumatriptan and dihydroergotamine on human 5-HT1B and 5-HT1D receptors expressed in various mammalian cell lines.
    Lesage AS; Wouters R; Van Gompel P; Heylen L; Vanhoenacker P; Haegeman G; Luyten WH; Leysen JE
    Br J Pharmacol; 1998 Apr; 123(8):1655-65. PubMed ID: 9605573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cloning of serotonin 5-HT(1) receptor subtypes from the chimpanzee, gorilla and Rhesus monkey and their agonist-induced guanosine 5'gamma(35)S triphosphate binding.
    Alberts GL; Pregenzer JF; Im WB; Slightom JL
    Neurosci Lett; 2000 Feb; 280(3):223-7. PubMed ID: 10675801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cloning and characterization of the guinea pig 5-HT1F receptor subtype: a comparison of the pharmacological profile to the human species homolog.
    Adham N; Bard JA; Zgombick JM; Durkin MM; Kucharewicz S; Weinshank RL; Branchek TA
    Neuropharmacology; 1997; 36(4-5):569-76. PubMed ID: 9225282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sequence and functional analysis of cloned guinea pig and rat serotonin 5-HT1D receptors: common pharmacological features within the 5-HT1D receptor subfamily.
    Wurch T; Palmier C; Colpaert FC; Pauwels PJ
    J Neurochem; 1997 Jan; 68(1):410-8. PubMed ID: 8978753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and serotonergic activity of 3-[2-(pyrrolidin-1-yl)ethyl]indoles: potent agonists for the h5-HT1D receptor with high selectivity over the h5-HT1B receptor.
    Sternfeld F; Guiblin AR; Jelley RA; Matassa VG; Reeve AJ; Hunt PA; Beer MS; Heald A; Stanton JA; Sohal B; Watt AP; Street LJ
    J Med Chem; 1999 Feb; 42(4):677-90. PubMed ID: 10052975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isochroman-6-carboxamides as highly selective 5-HT1D agonists: potential new treatment for migraine without cardiovascular side effects.
    Ennis MD; Ghazal NB; Hoffman RL; Smith MW; Schlachter SK; Lawson CF; Im WB; Pregenzer JF; Svensson KA; Lewis RA; Hall ED; Sutter DM; Harris LT; McCall RB
    J Med Chem; 1998 Jun; 41(13):2180-3. PubMed ID: 9632349
    [No Abstract]   [Full Text] [Related]  

  • 10. Binding of O-alkyl derivatives of serotonin at human 5-HT1D beta receptors.
    Glennon RA; Hong SS; Bondarev M; Law H; Dukat M; Rakhi S; Power P; Fan E; Kinneau D; Kamboj R; Teitler M; Herrick-Davis K; Smith C
    J Med Chem; 1996 Jan; 39(1):314-22. PubMed ID: 8568822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. F 11356, a novel 5-hydroxytryptamine (5-HT) derivative with potent, selective, and unique high intrinsic activity at 5-HT1B/1D receptors in models relevant to migraine.
    John GW; Pauwels PJ; Perez M; Halazy S; Le Grand B; Verscheure Y; Valentin JP; Palmier C; Wurch T; Chopin P; Marien M; Kleven MS; Koek W; Assie MB; Carilla-Durand E; Tarayre JP; Colpaert FC
    J Pharmacol Exp Ther; 1999 Jul; 290(1):83-95. PubMed ID: 10381763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alniditan, a new 5-hydroxytryptamine1D agonist and migraine-abortive agent: ligand-binding properties of human 5-hydroxytryptamine1D alpha, human 5-hydroxytryptamine1D beta, and calf 5-hydroxytryptamine1D receptors investigated with [3H]5-hydroxytryptamine and [3H]alniditan.
    Leysen JE; Gommeren W; Heylen L; Luyten WH; Van de Weyer I; Vanhoenacker P; Haegeman G; Schotte A; Van Gompel P; Wouters R; Lesage AS
    Mol Pharmacol; 1996 Dec; 50(6):1567-80. PubMed ID: 8967979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Benzylimidazolines as h5-HT1B/1D serotonin receptor ligands: a structure-affinity investigation.
    Law H; Dukat M; Teitler M; Lee DK; Mazzocco L; Kamboj R; Rampersad V; Prisinzano T; Glennon RA
    J Med Chem; 1998 Jun; 41(13):2243-51. PubMed ID: 9632357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stereoselective actions of the isomers of metitepine at 5-HT1D receptors in the guinea pig brain.
    Wilkinson LO; Hawkins LM; Beer MS; Hibert MF; Middlemiss DN
    Neuropharmacology; 1993 Mar; 32(3):205-8. PubMed ID: 8474615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differences in ligand binding profiles between cloned rabbit and human 5-HT1D alpha and 5-HT1D beta receptors: ketanserin and methiothepin distinguish rabbit 5-HT1D receptor subtypes.
    Bard JA; Kucharewicz SA; Zgombick JM; Weinshank RL; Branchek TA; Cohen ML
    Naunyn Schmiedebergs Arch Pharmacol; 1996; 354(3):237-44. PubMed ID: 8878052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular cloning of two partial serotonin 5-HT1D receptor sequences in mouse and one in guinea pig.
    Weydert A; Cloez-Tayarani I; Fillion MP; Simon-Chazottes D; Guenet JL; Fillion G
    C R Acad Sci III; 1992; 314(10):429-35. PubMed ID: 1521164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chimeric receptor analysis of the ketanserin binding site in the human 5-Hydroxytryptamine1D receptor: importance of the second extracellular loop and fifth transmembrane domain in antagonist binding.
    Wurch T; Colpaert FC; Pauwels PJ
    Mol Pharmacol; 1998 Dec; 54(6):1088-96. PubMed ID: 9855638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 5-hydroxytryptamine-moduline, a new endogenous cerebral peptide, controls the serotonergic activity via its specific interaction with 5-hydroxytryptamine1B/1D receptors.
    Massot O; Rousselle JC; Fillion MP; Grimaldi B; Cloëz-Tayarani I; Fugelli A; Prudhomme N; Seguin L; Rousseau B; Plantefol M; Hen R; Fillion G
    Mol Pharmacol; 1996 Oct; 50(4):752-62. PubMed ID: 8863819
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 2-(1-Naphthyloxy)ethylamines with enhanced affinity for human 5-HT1D beta (h5-HT1B) serotonin receptors.
    Ismaiel AM; Dukat M; Law H; Kamboj R; Fan E; Lee DK; Mazzocco L; Buekschkens D; Teitler M; Pierson ME; Glennon RA
    J Med Chem; 1997 Dec; 40(26):4415-9. PubMed ID: 9435911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The rat 5-hydroxytryptamine1B receptor is the species homologue of the human 5-hydroxytryptamine1D beta receptor.
    Adham N; Romanienko P; Hartig P; Weinshank RL; Branchek T
    Mol Pharmacol; 1992 Jan; 41(1):1-7. PubMed ID: 1732716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.